help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Published ahead of print on December 3, 2004, doi:10.1164/rccm.200404-558OC
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
200404-558OCv1
171/8/838    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Santus, P.
Right arrow Articles by Sala, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Santus, P.
Right arrow Articles by Sala, A.
American Journal of Respiratory and Critical Care Medicine Vol 171. pp. 838-843, (2005)
© 2005 American Thoracic Society
doi: 10.1164/rccm.200404-558OC

Original Article

Lipid Peroxidation and 5-Lipoxygenase Activity in Chronic Obstructive Pulmonary Disease

Pierachille Santus, Alessandra Sola, Paolo Carlucci, Francesca Fumagalli, Antonio Di Gennaro, Michele Mondoni, Chiara Carnini, Stefano Centanni and Angelo Sala

Institute of Respiratory Medicine, Ospedale S. Paolo; and Department of Pharmacological Sciences, Center for Cardiopulmonary Pharmacology, University of Milan, Milan, Italy

Correspondence and requests for reprints should be addressed to Angelo Sala, Ph.D., Department of Pharmacological Sciences, Center for Cardiopulmonary Pharmacology, Via Balzaretti 9, Milan 20133, Italy. E-mail: angelo.sala{at}unimi.it

We studied the urinary excretion of the isoprostane 8-iso-prostaglandin F2{alpha} as an index of in vivo oxidant stress, and the production of leukotriene (LT) B4 (LTB4) by neutrophils in subjects with chronic obstructive pulmonary disease (COPD) and normal subjects. Overnight urinary excretion of the isoprostane was significantly higher in patients with COPD than in control subjects, and LTB4 production by challenge of neutrophils obtained from patients with COPD was also significantly higher than that observed in control neutrophils. Treatment with a standardized polyphenol extract caused a significant decrease in isoprostane excretion, accompanied by a statistically significant increase of PaO2. Furthermore, changes in FEV1 significantly correlated with the changes in isoprostane urinary excretion observed from enrollment to the end of treatment. The results of this study suggest that enhanced oxidative stress in subjects with COPD is paralleled by the increased ability of neutrophils to synthesize the chemotactic factor LTB4, and may ultimately contribute to the infiltration/activation of neutrophils into the airways of subjects with COPD. Antioxidant treatment in subjects with COPD is effective in reducing oxidant stress as shown by the decrease of urinary isoprostane, a reduction that correlates with the severity of the disease, as indicated by changes in PaO2 and FEV1.

Key Words: leukotriene B4 • natural polyphenols • neutrophils • oxidative stress • urinary isoprostanes




This article has been cited by other articles:


Home page
 Cancer Prevention ResearchHome page
A. J. Duffield-Lillico, J. O. Boyle, X. K. Zhou, A. Ghosh, G. S. Butala, K. Subbaramaiah, R. A. Newman, J. D. Morrow, G. L. Milne, and A. J. Dannenberg
Levels of Prostaglandin E Metabolite and Leukotriene E4 Are Increased in the Urine of Smokers: Evidence that Celecoxib Shunts Arachidonic Acid into the 5-Lipoxygenase Pathway
Cancer Prevention Research, April 1, 2009; 2(4): 322 - 329.
[Abstract] [Full Text] [PDF]

Home page
 Ther Adv Respir DisHome page
I. Rahman
Review: Antioxidant therapeutic advances in COPD
Therapeutic Advances in Respiratory Disease, December 1, 2008; 2(6): 351 - 374.
[Abstract] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
P. Szulakowski, A. J. L. Crowther, L. A. Jimenez, K. Donaldson, R. Mayer, T. B. Leonard, W. MacNee, and E. M. Drost
The Effect of Smoking on the Transcriptional Regulation of Lung Inflammation in Patients with Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med., July 1, 2006; 174(1): 41 - 50.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
L. M. Fabbri, F. Luppi, B. Beghe, and K. F. Rabe
Update in chronic obstructive pulmonary disease 2005.
Am. J. Respir. Crit. Care Med., May 15, 2006; 173(10): 1056 - 1065.
[Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
K. Juul, A. Tybjaerg-Hansen, S. Marklund, P. Lange, and B. G. Nordestgaard
Genetically Increased Antioxidative Protection and Decreased Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med., April 15, 2006; 173(8): 858 - 864.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
R. F. Foronjy, O. Mirochnitchenko, O. Propokenko, V. Lemaitre, Y. Jia, M. Inouye, Y. Okada, and J. M. D'Armiento
Superoxide Dismutase Expression Attenuates Cigarette Smoke- or Elastase-generated Emphysema in Mice
Am. J. Respir. Crit. Care Med., March 15, 2006; 173(6): 623 - 631.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
H. Yasuda, M. Yamaya, K. Nakayama, S. Ebihara, T. Sasaki, S. Okinaga, D. Inoue, M. Asada, M. Nemoto, and H. Sasaki
Increased Arterial Carboxyhemoglobin Concentrations in Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med., June 1, 2005; 171(11): 1246 - 1251.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2005 American Thoracic Society